A randomized, open-label, 5-period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults.
Richard B LiptonDetlef AlbrechtMaria BermudezJerry HuElizabeth HusseyJeff LevyPublished in: Headache (2024)
was comparable to IM DHE.